Diagnosis of influenza virus: Coming to grips with the molecular era

Molecular Diagnosis

Volumn 6, Issue 4, 2001, Pages 291-305

  Taubenberger, Jeffery K ^a   Layne, Scott P ^b  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Influenza virus; Pandemic; PCR; Review; RNA

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE;

DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; GENETIC VARIABILITY; HUMAN; INFLUENZA; INFLUENZA VIRUS; MOLECULAR GENETICS; MORTALITY; NONHUMAN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; STRAIN DIFFERENCE; UNITED STATES; VIRAL GENETICS;

EID: 0035678866     PISSN: 10848592     EISSN: None     Source Type: Journal    
DOI: 10.1054/modi.2001.28063     Document Type: Article

References (82)

1. Global epidemiology of influenza: Past and present
2. The impact of influenza epidemics on hospitalizations
3. Pandemic versus epidemic influenza mortality: A pattern of changing age distribution
4. The geography and mortality of the 1918 influenza pandemic
5. Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene
6. Evolution and ecology of influenza A viruses
7. Preparing for pandemic influenza: The need for enhanced surveillance
8. Influenza in the world, 1 October 1999-30 September 2000
9. Pandemic influenza: Confronting a re-emergent threat
10. Predictions for future human influenza pandemics
11. The economic impact of pandemic influenza in the United States: Priorities for intervention
12. Orthomyxoviruses
13. Update: Influenza activity - United States and worldwide, 1999-2000 season, and composition of the 2000-01 influenza vaccine
14. Prevention and treatment of influenza
15. Amantidine and rimantidine - Clinical aspects
16. Zanamivir in the prevention of influenza among healthy adults: A randomized controlled trial
17. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza
18. Orthomyxoviridae: The viruses and their replication
19. Influenza pandemics in perspective
20. On the origin of the human influenza virus subtypes H2N2 and H3N2
21. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics
22. Swine influenza A at Fort Dix, New Jersey (January-February 1976). I. Case finding and clinical study of cases
23. The 1976 experience
24. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness
25. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus
26. Influenza viruses
27. Influenza
28. Type- and subtype-specific detection of influenza viruses in clinical specimens by rapid culture assay
29. Comparison of enzyme-linked immunosorbent assay, indirect immunofluorescence assay, and virus isolation for detection of respiratory viruses in nasopharyngeal secretions
30. Comparison of directigen FLU-A with viral isolation and direct immunofluorescence for rapid detection and identification of influenza A virus
31. Comparison of rapid diagnostic techniques for respiratory syncytial and influenza A virus respiratory infections in young children
32. Comparison of rapid detection methods for influenza A virus and their value in healthcare management of institutionalized geriatric patients
33. SimilFluor respiratory screen for rapid detection of multiple respiratory viruses in clinical specimens by immunofluorescence staining
34. Comparison of a new neuraminidase detection assay with an enzyme immunoassay, immunofluorescence, and culture for rapid detection of influenza A and B viruses in nasal wash specimens
35. Detection and identification of human influenza viruses by the polymerase chain reaction
36. Typing and subtyping of influenza viruses in clinical samples by PCR
37. Multiplex reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996
38. Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses
39. Influenza diagnosis: From dark isolation into the molecular light
40. Rapid virological surveillance of community influenza infection in general practice
41. A comparative study of immunocapture ELISA and RT-PCR for screening clinical samples from Southern Greece for human influenza virus types A and B
42. Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene
43. Evaluation of a rapid optical immunoassay for influenza viruses (FLU OIA test) in comparison with cell culture and reverse transcription-PCR
44. Simultaneous detection and typing of influenza viruses A and B by a nested reverse transcription-PCR: Comparison to virus isolation and antigen detection by immunofluorescence and optical immunoassay (FLU OIA)
45. Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples
46. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR
47. Typing and subtyping influenza virus using DNA microarrays and multiplex reverse transcriptase PCR
48. PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines
49. Gene analysis of reassortant influenza virus by RT-PCR followed by restriction enzyme digestion
50. A simple restriction fragment length polymorphism-based strategy that can distinguish the internal genes of human H1N1, H3N2, and H5N1 influenza A viruses
51. Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: Multiple evolutionary pathways and sequential amino acid changes at key antigenic sites
52. Forecasting the epidemic potential of influenza virus variants based on their molecular properties
53. HA1 domain of influenza A (H3N2) viruses in Finland in 1989-1995: Evolution, egg-adaptation and relationship to vaccine strains
54. Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses
55. Predicting the evolution of human influenza A
56. Long term trends in the evolution of H(3) HA1 human influenza type A
57. The Wilhelmine E. Key 1999 invitational lecture. Predicting the evolution of human influenza A
58. Use of polymerase chain reaction to detect swine influenza virus in nasal swab specimens
59. A PCR based method for the identification of equine influenza virus from clinical samples
60. Type-and subtype-specific RT-PCR assays for avian influenza A viruses (AIV)
61. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range
62. Molecular correlates of influenza A H5N1 virus pathogenesis in mice
63. Direct reverse transcriptase PCR to determine virulence potential of influenza A viruses in birds
64. Initial genetic characterization of the 1918 "Spanish" influenza virus
65. Characterization of the 1918 "Spanish" influenza virus neuraminidase gene
66. From the cover: Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes
67. The 1918 flu and other influenza pandemics: "Over there" and back again
68. The 1918 influenza virus: A killer comes into view
69. The pathologic anatomy of influenzal bronchopneumonia
70. Comments on the pathology and bacteriology of fatal influenza cases, as observed at Camp Devens, Mass
71. Influenza virus A pathogenicity: The pivotal role of hemagglutinin
72. Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus
73. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems
74. Sequencing influenza A from the 1918 pandemic, investigating its virulence, and averting future outbreaks
75. Tackling grand challenges with powerful technologies
76. Global laboratory against influenza
77. Laboratory firepower for infectious disease research
78. Influenza A virus recycling revisited